SCM
ONCT

Sio Capital Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Sio Capital Management’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,167
Closed -$2.69M – 97
2021
Q1 		$2.69M Hold
16,167
– – 0.55% 56
2020
Q4 		$1.58M Buy
+16,167
New +$1.02M 0.32% 71

Other funds holding ONCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

Sio Capital Management's ONCT Position: Q2 2021 in Review

Sio Capital Management sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2021, closing a stake of 16,167 shares — an estimated $2.69M sold.

Sio Capital Management first reported a position in ONCT in Q4 2020 and held it in 2 quarters. The position peaked at $2.69M in Q1 2021. 84 funds tracked by Wall St. Rank hold ONCT as of Q2 2021.

  • Sio Capital Management reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Sio Capital Management sold 16,167 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $2.69M.
  • Sio Capital Management first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Sio Capital Management's Oncternal Therapeutics, Inc. Common Stock position peaked at $2.69M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Sio Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.